Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Rockefeller University other research news

Apo E-deficient mice typically develop extensive atherosclerosis.

As described in the Proceedings

Read the full 126 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE